Paul Stanley

Paul Stanley has extensive experience in the field of quality assurance and compliance in the pharmaceutical industry. Paul currently holds the position of Vice President, Head of Quality at Astria Therapeutics, Inc. since December 2021. Prior to this, they were the Vice President of Quality at Frequency Therapeutics from January 2021 to December 2021.

From August 2019 to December 2020, Paul served as the Executive Director of Quality Assurance at Catabasis Pharmaceuticals, Inc. Before that, they held the role of Senior Director, Quality Assurance at Visterra Inc. from 2017 to August 2019.

Paul Stanley's experience also includes working at Alexion Pharmaceuticals, Inc. where they served as the Senior Director of Quality Compliance. During their tenure at Alexion Pharmaceuticals, they managed a highly agile and collaborative Quality team, oversaw the implementation and execution of core quality systems, and provided expertise and support to quality control and analytical development organizations.

Prior to their time at Alexion Pharmaceuticals, Paul Stanley held various positions at Genzyme, including Senior Director of Quality/ Site Quality Head, Director of Quality Control Microbiology, and Manager of Quality Control Raw Materials and Biopolymers. In these roles, they directed and managed QA/QC/QE functions, provided support for the manufacturing of medical devices and biologics, and oversaw laboratory testing and inspection of raw materials.

Overall, Paul Stanley has a wealth of experience and expertise in quality assurance, compliance, and team management within the pharmaceutical industry.

Paul Stanley attended the University of Massachusetts Amherst, where they obtained a Bachelor of Science degree in Microbiology. Paul also pursued further education at the Boston College Carroll School of Management, earning an MBA with a specialization in Organizational Behavior. The specific years of enrollment for both degrees are not provided.